A real-world study in advanced non-small cell lung cancer with de novo brain metastasis

Brain metastases are the major cause of life-expectancy shortened for patients with lung cancer. The prognostic value of EGFR mutation subtypes and survival benefit of EGFR-tyrosine kinase inhibitors (TKIs) in advanced non-small cell lung cancer (NSCLC) patients with de novo brain metastasis is stil...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:J Cancer
Päätekijät: Lei, Lei, Wang, Wen-xian, Wang, Dong, Lin, Li, Zhu, You-cai, Wang, Hong, Wang, Li-ping, Zhuang, Wu, Fang, Mei-yu, Wan, Bing, Feng, Hui-jing, Xu, Chun-wei
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Ivyspring International Publisher 2021
Aiheet:
Research Paper
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7847653/
https://ncbi.nlm.nih.gov/pubmed/33531991
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/jca.51411
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia